AHL Partners’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$3.85M Sell
77,264
-1,801
-2% -$89.5K 0.06% 557
2017
Q3
$4.58M Sell
79,065
-57,468
-42% -$3.42M 0.08% 426
2017
Q2
$9.17M Buy
136,533
+23,886
+21% +$1.51M 0.2% 116
2017
Q1
$7.38M Buy
112,647
+106,702
+1,795% +$6.59M 0.16% 198
2016
Q4
$338K Sell
5,945
-26,735
-82% -$1.55M 0.01% 944
2016
Q3
$1.94M Sell
32,680
-39,750
-55% -$2.39M 0.07% 391
2016
Q2
$4.74M Buy
72,430
+60,722
+519% +$4.13M 0.26% 88
2016
Q1
$811K Sell
11,708
-47,364
-80% -$3.16M 0.05% 448
2015
Q4
$4.34M Buy
59,072
+33,064
+127% +$2.35M 0.34% 96
2015
Q3
$1.84M Sell
26,008
-86,311
-77% -$7M 0.29% 89
2015
Q2
$9.77M Buy
112,319
+15,768
+16% +$1.19M 0.39% 1
2015
Q1
$7.09M Buy
96,551
+30,429
+46% +$2.16M 0.28% 47
2014
Q4
$4.75M Buy
66,122
+19,532
+42% +$1.35M 0.25% 76
2014
Q3
$3.22M Buy
+46,590
New +$3.28M 0.25% 153

Other funds holding LPNT

AHL Partners's LPNT Position: Q4 2017 in Review

AHL Partners reduced its LifePoint Health, Inc. (LPNT) stake by 2.3% in Q4 2017, selling an estimated $89.5K and leaving 77,264 shares worth $3.85M. The position accounts for 0.06% of the portfolio, ranked #557.

AHL Partners first reported a position in LPNT in Q3 2014 and has held it in 14 quarters since. The position peaked at $9.77M in Q2 2015. 212 funds tracked by Wall St. Rank hold LPNT as of Q4 2017.

  • AHL Partners held 77,264 shares of LifePoint Health, Inc. worth $3.85M as of Q4 2017.
  • AHL Partners sold 1,801 LifePoint Health, Inc. shares in Q4 2017, an estimated $89.5K.
  • LifePoint Health, Inc. made up 0.06% of AHL Partners's portfolio in Q4 2017, its #557 holding.
  • AHL Partners first reported a position in LifePoint Health, Inc. in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's LifePoint Health, Inc. position peaked at $9.77M in Q2 2015.
  • 212 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.